A TMAO blood test measures the concentration of trimethylamine N-oxide in your plasma, a small molecule produced when gut bacteria digest certain nutrients in food and your liver processes what they leave behind. The test has drawn serious clinical interest because elevated TMAO levels have been linked to roughly double the risk of major cardiovascular events in meta-analyses, and the molecule appears to play active roles in promoting artery-clogging plaque and blood clots. Yet the test is not yet part of routine bloodwork at most hospitals, and interpreting the result requires understanding a surprisingly tangled relationship between your diet, your gut microbiome, your kidneys, and your genetics.
How TMAO Gets Into Your Blood
TMAO starts with what you eat. When you consume foods rich in choline, carnitine, or lecithin, bacteria living in your gut break those nutrients down into a gas called trimethylamine, or TMA. Two major bacterial enzyme systems handle this job: a choline-specific enzyme called CutC (a glycyl radical enzyme) and a carnitine-targeted enzyme called CntA (a monooxygenase).1Methods. Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut The TMA these bacteria produce passes quickly through the gut wall into the bloodstream and travels to the liver, where a liver enzyme called FMO3 converts it to TMAO, which the kidneys then clear through urine.2PubMed Central. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation FMO3 is the dominant player here; among the five related enzymes humans carry, it is far and away the most active at producing TMAO.3Biochemical Pharmacology. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: Selective catalysis by fmo3
This means your TMAO level is not just a readout of what you ate for dinner. It reflects an entire chain: the nutrients in your food, which bacteria colonize your gut, how efficiently your liver’s FMO3 enzyme works, and how well your kidneys excrete the end product. A problem at any link in that chain can push your levels higher or pull them lower, which is part of why the same meal produces wildly different TMAO spikes in different people.
What the Test Actually Involves
Clinically, TMAO is measured from a fasting blood draw. The sample is typically frozen and analyzed using a technique called liquid chromatography-tandem mass spectrometry (LC-MS/MS), which identifies TMAO by its molecular weight and fragmentation pattern. Large research studies, including the Multi-Ethnic Study of Atherosclerosis, have used this approach and report high accuracy and low variability between batches.4Scientific Reports. Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis The test is available from some specialty labs and direct-to-consumer health companies, though it is not yet a standard panel item ordered by most primary-care doctors.
There is no universally agreed-upon cutoff for what counts as a “high” TMAO level. Studies that find cardiovascular risk associations generally compare people in the highest quartile of TMAO to those in the lowest, and the absolute numbers vary by population and lab method. If you order the test, expect to see your result in micromolar units, and expect the reference range to depend on which lab ran it. That ambiguity is one reason the test remains more of a research and specialty-cardiology tool than a mainstream screening measure.
Why Cardiologists Care About TMAO
The cardiovascular connection is the main reason TMAO testing has gained attention. A systematic review and meta-analysis found that people with high TMAO levels had roughly twice the risk of major adverse cardiovascular events and more than triple the risk of dying from any cause compared to people with low levels.5PubMed. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis In patients with stable coronary artery disease, elevated TMAO independently predicted five-year death risk even after accounting for traditional risk factors, kidney function, and inflammation markers.6PubMed Central. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease In heart failure patients, the story is similar: high TMAO predicted five-year mortality after adjusting for other known risks.7PubMed Central. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure
Elevated TMAO has also been tied to the severity and spread of artery disease. In one study of patients undergoing cardiac catheterization, those with high TMAO had nearly five times the odds of having complex, diffuse coronary lesions, even after controlling for the usual suspects like cholesterol, blood pressure, and diabetes.8PubMed Central. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
How TMAO Damages Blood Vessels
The reason elevated TMAO is not just a bystander marker but a likely active player comes from lab and animal research showing specific mechanisms of harm. TMAO promotes inflammation in the cells lining blood vessel walls by activating a molecular alarm system called the NLRP3 inflammasome, which triggers a cascade of inflammatory signals.9PubMed Central. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway That inflammation makes artery walls stickier, more prone to plaque buildup, and more vulnerable to rupture.10PubMed Central. The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
TMAO also disrupts the barrier function of endothelial cells, the thin layer lining your blood vessels, making them leakier. Research has shown this disruption happens through the same NLRP3 inflammasome pathway, and blocking that pathway protects endothelial cells from TMAO-induced damage.11PubMed Central. Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome
Beyond inflammation, TMAO makes platelets (the tiny blood cells responsible for clotting) jumpier. Direct exposure to TMAO enhances platelet activation, making them more likely to clump together and form clots.12PubMed Central. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk There is even preliminary evidence that TMAO may reduce the effectiveness of clopidogrel, a widely prescribed blood thinner, potentially by acting on the same platelet receptor the drug targets.13Scientific Reports. TMAO: a potential mediator of clopidogrel resistance If that holds up in larger human studies, it could become clinically important for patients on antiplatelet therapy.
The Kidney Connection
Your kidneys are responsible for clearing TMAO from the blood, so kidney function has an outsized effect on your levels. People with chronic kidney disease have significantly elevated TMAO, and the worse their kidney function, the higher their TMAO tends to be.14PubMed Central. TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review A multicenter study found that TMAO strongly correlated with kidney function markers and could identify reduced kidney filtration with high accuracy.15PubMed Central. Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study
This creates a feedback problem. Damaged kidneys clear less TMAO, so levels climb. Higher TMAO promotes more vascular inflammation and damage, which further harms the kidneys. If you see a high TMAO result and you already know your kidney function is impaired, the number likely reflects that clearance bottleneck as much as your diet or microbiome. It also means that dietary interventions alone may not be enough to bring the number down for people with advanced kidney disease.
What Drives Your TMAO Level Up
Red meat is the strongest dietary driver. A controlled feeding study found that a chronic red-meat diet raised plasma TMAO about three-fold on average compared to white-meat or plant-protein diets, with some individuals seeing more than a ten-fold increase.16European Heart Journal. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women That is because red meat is rich in both carnitine and choline, the two main precursors bacteria convert to TMA.
Eggs are another notable source of choline, and eating them does raise TMAO. One dose-response study found that about 14% of the choline in eggs ended up as TMAO, though there was considerable person-to-person variation in the response.17PubMed Central. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study
Fish introduces a wrinkle that confuses both patients and clinicians. Many types of fish and seafood naturally contain preformed TMAO, meaning the molecule itself is already in the food rather than being produced by gut bacteria. That TMAO can be absorbed directly into the bloodstream, spiking your level after a seafood meal without the usual bacterial processing step.18Clinical Kidney Journal. The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison This creates what researchers have called a puzzling paradox: fish raises TMAO levels, yet populations that eat a lot of fish tend to have lower rates of heart disease.19PubMed Central. Microbial trimethylamine-N-oxide as a disease marker: something fishy? One working explanation is that the health effects of TMAO depend on its source and what else comes along with it in the food. Fish also delivers omega-3 fatty acids and other anti-inflammatory compounds that may counterbalance or outweigh the TMAO spike.
Your Gut Microbiome Makes a Huge Difference
The same meal does not produce the same amount of TMAO in everyone, and the biggest reason is differences in gut bacteria. Your microbial community determines how efficiently dietary choline and carnitine get converted to TMA in the first place. Omnivores carry gut bacteria with a significantly greater capacity to produce TMA from carnitine than vegans or vegetarians do, with fecal cultures from omnivores showing up to ten-fold greater conversion of the intermediate compound gamma-butyrobetaine to TMA.20JCI Insight. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans In other words, years of eating meat reshape which bacteria thrive in your gut, and those bacteria become increasingly efficient at cranking out the precursor to TMAO.
This microbial adaptation has been documented across species as well. The genes responsible for bacterial TMA production (cutC and cntA) are more abundant in the guts of omnivores and carnivores than herbivores, and the carnitine-processing gene cntA is essentially absent from herbivore guts.21Frontiers in Microbiology. Potential TMA-Producing Bacteria Are Ubiquitously Found in Mammalia The practical implication: if you have been eating meat-heavy meals for years, your gut community is primed to produce more TMAO from the same foods than someone who has been plant-based for a long time.
Can You Lower Your TMAO
Dietary shifts are the most accessible lever. A review of studies on animal-based versus plant-based diets found that six out of eight studies reported that plant-based eating patterns reduced plasma or urinary TMAO.22PubMed. The Influence of Animal- or Plant-Based Diets on Blood and Urine Trimethylamine-N-Oxide (TMAO) Levels in Humans A short-term trial of a Mediterranean-style diet showed significant drops in blood TMAO in both men and women.23PubMed Central. Short-Term Mediterranean Dietary Intervention Reduces Plasma Trimethylamine-N-Oxide Levels in Healthy Individuals One study found that a Mediterranean diet with low unprocessed red meat intake (about 200 grams per week) reduced fasting TMAO, while a Mediterranean diet that included moderate red meat (about 500 grams per week) did not.24British Journal of Nutrition. Adopting a Mediterranean-style eating pattern with low, but not moderate, unprocessed, lean red meat intake reduces fasting serum trimethylamine N-oxide (TMAO) in adults who are overweight or obese The dose of red meat matters, not just the overall eating pattern.
Researchers are also exploring more targeted approaches. A compound called DMB (3,3-dimethyl-1-butanol), a structural analog of choline found naturally in some foods like balsamic vinegar and olive oil, was shown to inhibit the bacterial enzymes that produce TMA and reduce TMAO levels in mice on high-choline or high-carnitine diets.25PubMed Central. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis The appeal of DMB-like compounds is that they block TMA production without killing the bacteria, avoiding the collateral damage of antibiotics. Animal studies with resveratrol, a polyphenol found in red wine and grapes, have also shown reductions in TMAO through remodeling of the gut microbiome.26PubMed Central. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota None of these targeted therapies are available for human clinical use yet, but they represent an active area of drug development.
The Causality Question
A legitimate criticism of TMAO testing is whether high TMAO actually causes cardiovascular disease or is merely a marker of something else going wrong. Many of the human studies are observational: they show that people with higher TMAO are more likely to have heart attacks and die, but that does not prove TMAO itself is the culprit. People with high TMAO also tend to eat more red meat, have worse kidney function, or carry different microbiome profiles, any of which could independently explain the risk.
The case for TMAO being more than an innocent bystander rests on the mechanistic lab work described above. TMAO directly inflames blood vessel walls, makes platelets stickier, and promotes plaque formation in animal models. Clinical researchers broadly consider TMAO an independent risk factor for cardiovascular disease.27PubMed Central. Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy But no large randomized human trial has yet shown that lowering TMAO specifically reduces heart attacks or strokes. The evidence is strong enough to be taken seriously and weak enough that mainstream guidelines have not yet endorsed routine TMAO screening for the general population.
TMAO Beyond the Heart
Cardiovascular risk dominates the TMAO conversation, but the molecule appears in other medical contexts. Research suggests that TMAO levels rise with age-related cognitive decline, and the compound promotes oxidative stress, mitochondrial problems, and synaptic damage in brain tissue.28PubMed. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders This is still early-stage research, and no one is using TMAO tests to screen for dementia risk. But it fits a broader pattern of the gut-brain axis influencing neurological health through metabolites produced by intestinal bacteria.
There is also an interesting connection to diabetic complications. In cell and animal studies, TMAO worsened the leakiness of blood vessels under high-glucose conditions and increased inflammatory markers like IL-6 and TNF-alpha.29PubMed Central. Trimethylamine N-oxide aggravates vascular permeability and endothelial cell dysfunction under diabetic condition If TMAO amplifies vascular damage in people with diabetes, it could partly explain why gut-microbiome changes and dietary patterns influence diabetic complications beyond what glucose control alone predicts.
Who Should Consider Getting Tested
Right now, TMAO testing is most useful for people who already have cardiovascular risk factors and want additional information to guide lifestyle changes. If you have a history of heart disease, heart failure, or chronic kidney disease, a high TMAO result adds another data point suggesting that dietary modification, particularly reducing red meat, could be beneficial. The test is less useful as a standalone screening tool for healthy people with no known risk, both because the reference ranges are not standardized and because the actionable response (eat less red meat, eat more plants) is generally good advice regardless of the number.
If you do get tested, keep in mind the confounders. A fish dinner the night before can spike your levels because of preformed TMAO in the fish itself. Kidney function affects clearance. A single measurement captures a snapshot that may not reflect your usual baseline. Some clinicians recommend fasting overnight and avoiding seafood for 24 to 48 hours before the draw to get a result that better represents your gut-bacteria-driven TMAO production rather than a transient dietary spike.
TMAO in the Deep Sea
TMAO shows up in an entirely different context in marine biology that occasionally confuses people researching the topic. Deep-sea fish accumulate large amounts of TMAO in their tissues as a natural adaptation to the crushing pressures of the ocean. The molecule stabilizes their proteins against pressure-induced damage, and its concentration rises with depth, from modest levels near the surface to high concentrations in fish living nearly five kilometers down.30PubMed Central. Marine fish may be biochemically constrained from inhabiting the deepest ocean depths This is part of why different species of fish and seafood contain such variable amounts of preformed TMAO, and why the fish paradox in human cardiovascular research is so hard to resolve. The TMAO in your salmon fillet serves a completely different biological purpose than the TMAO circulating in your arteries after your gut bacteria processed a steak.